You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Cognitive Residential Heat Pumps Fault Detection and Diagnostic Datalogger

    SBC: MANAGEMENT SCIENCES INC            Topic: 9010173R

    During Phase I, Management Sciences, Inc. (MSI) proved feasibility of adapting their current technology into a product capable of improving performance resulting in increased efficiency and extended life cycles of heat pumps. The resultant product is a tool named the Heat Pump Sentient (HP-Sentient). The HP-Sentient will improve performance and reduce maintenance costs through aggressive goal-seek ...

    SBIR Phase II 2015 Department of CommerceNational Institute of Standards and Technology
  2. IGF OT IGF SBIR PHASE I TOPIC SYSTEMIC TARGETED RADIONUCLIDE THERAPY FOR CANCER TREATMENT PERIOD OF PERFORMANCE

    SBC: Icagen, Inc.            Topic: NCI

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  3. HLS13-13 Albumin nanoparticle based technology to treat ARDS

    SBC: CELL BIOLOGICS INC            Topic: NHLBI

    DESCRIPTION provided by applicant Severe infections various types of trauma and other etiologic factors can cause ALI that rapidly morphs into ARDS The incidence of ALI ARDS is around in adults in US alone Despite medical advances and better management through ventilation intervention the mortality is still unacceptably high at This problem is likely to escalate given the a ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  4. Mapping electrogram morphology recurrence for atrial fibrillation ablation

    SBC: GOLD T-TECH, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant Atrial fibrillation AF is the most common diagnosed arrhythmia with the number Americans diagnosed with AF estimated at million and continuing to increase as the population ages Electrical activity during AF is characterized by complex activation patterns that are difficult to map However there is growing evidence that AF is driven by stable sources i ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  5. Tumor-specific fluorescent cocktail enables image-guided cytoreductive surgery.

    SBC: On Target Laboratories, Inc.            Topic: 102

    DESCRIPTION provided by applicant Lung cancer remains the leading cause of cancer related deaths worldwide Surgical removal of the tumor is the best therapeutic option for patients with non small cell lung cancer yet up to of patients still leave the operating room with deposits of cancer left behind Advances in CAT and PET scans have provided surgeons with helpful radiographic imaging i ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  6. Multi-Source E-Beam kV X-Ray Tube for Image-Guided Radiotherapy

    SBC: Telesecurity Sciences, Inc.            Topic: 102

    DESCRIPTION provided by applicant This project will lead to the development of an optimized X ray tube with focal spots that can be placed immediately below and around the multi leaf collimator MLC of a radiotherapy system By steering a focused electron beam e beam on a series of cooled tungsten targets in sequence this system will provide a set of projection images that can be reco ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder

    SBC: LOHOCLA RESEARCH CORPORATION            Topic: 150

    DESCRIPTION provided by applicant Alcohol Use Disorder affects of the U S population ages and older and costs society over $ billion per year in direct medical costs accidents and lost productivity Current pharmacotherapy is only modestly effective and has to be used in conjunction with psychosocial treatment Primary care physicians are ill equipped to provide the currently neces ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  8. Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy

    SBC: STRYKAGEN CORPORATION            Topic: NIAMS

    DESCRIPTION provided by applicant Duchenne muscular dystrophy is caused by mutations in the dystrophin gene resulting in the loss of the dystrophin glycoprotein complex in skeletal muscle Loss of dystrophin results in reduced sarcolemmal integrity progressive muscle damage and compromised muscle function There is currently no cure and limited treatment options for DMD and all affected child ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Quantitative biomarkers of T1D peripheral neuropathy using functional imaging

    SBC: VisionQuest Biomedical Inc            Topic: NIDDK

    DESCRIPTION provided by applicant Diabetes affects an estimated million people worldwide including more than million Americans Diabetic patients are at risk for a wide array of complications including heart disease kidney disease nephropathy ocular diseases diabetic retinopathy and diabetic foot peripheral neuropathy Fifteen percent of diabetics wil develop a foot ulcer as a ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Mitigating Taxol-Induced Neuropathy through Modulation of the NMDA Receptor

    SBC: Naurex, Inc            Topic: 102

    DESCRIPTION provided by applicant Taxol paclitaxel is the one of the most widely used chemotherapy agents and is a first line treatment for ovarian breast lung and colon cancer Despite its well documented anti cancer properties taxol is known to cause chemotherapy induced peripheral neuropathy CIPN CIPN affects approximately of all chemotherapy patients and the neuropathic ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government